FilingReader Intelligence

Fosun Pharma schedules AGM, seeks shareholder approval for key initiatives

June 21, 2025 at 05:12 AM UTC•By FilingReader AI

Shanghai Fosun Pharmaceutical Group (SSE:600196) will hold its 2024 Annual General Meeting (AGM) at the Shanghai Sky Villa Hotel on June 24, 2025, followed by class meetings for A and H shareholders. Key items for shareholder consideration include the 2024 Annual Report, director and supervisor reports, and a profit distribution plan.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Fosun Pharma's Indicative Announcement on the Convening of the 2024 Annual General Meeting, the First A Shareholders' Class Meeting in 2025 and the First H Shareholders' Class Meeting in 2025June 20, 2025 at 08:00 AM UTC

Supplementary Source Documents

Fosun Pharma's announcement on the completion of private investment fund filing for the investment fund it participated in establishingJune 20, 2025 at 08:00 AM UTC

Shanghai Fosun Pharmaceutical Group

SSE:600196•Shanghai Stock Exchange

PharmaceuticalsShanghai Blue Chip

RSS feed for Shanghai Fosun Pharmaceutical Group

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →